NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Other Non-Current Assets (2021 - 2025)

NewcelX (NCEL) posted quarterly Other Non-Current Assets of $283.0 for Q2 2025, little changed quarter-over-quarter from $283.0 in Q4 2024.

NewcelX (NCEL) Other Non-Current Assets (2021 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Other Non-Current Assets for 5 consecutive years, with $283.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Other Non-Current Assets changed N/A year-over-year to $283.0; the TTM figure through Jun 2025 stood at $283.0 (changed N/A YoY), while the FY2024 annual figure was $283.0, down 98.32% from the prior year.
  • Other Non-Current Assets was little changed at $283.0 in Q2 2025 per NCEL's latest filing, from $283.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $16885.0 in Q4 2023 and bottomed at $283.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $9418.7 across 5 years, with a median of $12044.0 in 2021.
  • Annual changes were most pronounced in 2023 — Other Non-Current Assets jumped 39.05% — and 2024, when it plunged 98.32%.
  • NewcelX's Other Non-Current Assets stood at $12044.0 in 2021, then gained by 0.82% to $12143.0 in 2022, then surged by 39.05% to $16885.0 in 2023, then slumped by 98.32% to $283.0 in 2024, then changed by 0.0% to $283.0 in 2025.
  • Business Quant data shows NCEL's Other Non-Current Assets at $283.0 in Q2 2025, $283.0 in Q4 2024, and $16885.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.31 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 124.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 618.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 109.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 65.13 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 202.31 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 104.44 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 62.96 Mn
10 NewcelX 12.54 Mn 10.34 Mn - 296,000.00

Historic Data

Download Data
DateValue
Jun 30, 2025 283.00
Dec 31, 2024 283.00
Dec 31, 2023 16,885.00
Jun 30, 2023 12,558.00
Dec 31, 2022 12,143.00
Jun 30, 2022 11,735.00
Dec 31, 2021 12,044.00